Autophagy inhibitor 3-methyladenine mitigates the severity of colitis in aged mice by inhibiting autophagy

Background: The elderly ulcerative colitis (UC) patients pose unique challenges due to their comorbidities, diminished functional capacity, and heightened risk of treatment-related complications. Thus, finding a safe and effective treatment for this age group is crucial. Aim: This study investigates...

Full description

Saved in:
Bibliographic Details
Main Authors: Ailing Liu, Hongying Wang, Hong Lv, Hong Yang, Yue Li, Jiaming Qian
Format: Article
Language:English
Published: Elsevier 2025-03-01
Series:Experimental Gerontology
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0531556525000257
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832542436070522880
author Ailing Liu
Hongying Wang
Hong Lv
Hong Yang
Yue Li
Jiaming Qian
author_facet Ailing Liu
Hongying Wang
Hong Lv
Hong Yang
Yue Li
Jiaming Qian
author_sort Ailing Liu
collection DOAJ
description Background: The elderly ulcerative colitis (UC) patients pose unique challenges due to their comorbidities, diminished functional capacity, and heightened risk of treatment-related complications. Thus, finding a safe and effective treatment for this age group is crucial. Aim: This study investigates the role of autophagy in the pathogenesis of UC in young and elderly patients, and explores the therapeutic potential and mechanisms of autophagy modulators in aged mice with dextran sulfate sodium (DSS)-induced colitis. Methods: Colonic biopsies were collected from young and old UC patients as well as comparable healthy subjects. Young (6–8 weeks) and aged (56 weeks) C57BL/6 mice were treated with DSS to induce acute colitis model. The autophagy inhibitor 3-methyladenine was administered intraperitoneally to aged DSS-induced mice. The autophagy activity was detected by the protein expressions of LC3B-II, p62 and ATG5 by western blot and immunohistochemistry. The levels of TNF -α, IL-6, CCL4, CXCL12 and CD86 were measured by qRT-PCR. The transcriptional activity of NF-κB was measured by electrophoretic mobility shift assay (EMSA). Results: Increased autophagy activity was observed in aged DSS-induced mice. Treatment with 3-methyladenine suppressed autophagy in intestinal epithelial cells (IECs) and alleviated colitis severity. Additionally, 3-methyladenine reduced macrophage recruitment, decreased IL-6 levels, and inhibited NF-κB signaling, thereby mitigating inflammation. Conclusion: Significant differences in autophagy activity were identified between young and aged DSS-induced mice. These findings underscore the potential therapeutic benefits of autophagy inhibition in elderly UC patients.
format Article
id doaj-art-3f88727446e540c2a6a9474df3a79f90
institution Kabale University
issn 1873-6815
language English
publishDate 2025-03-01
publisher Elsevier
record_format Article
series Experimental Gerontology
spelling doaj-art-3f88727446e540c2a6a9474df3a79f902025-02-04T04:10:18ZengElsevierExperimental Gerontology1873-68152025-03-01201112697Autophagy inhibitor 3-methyladenine mitigates the severity of colitis in aged mice by inhibiting autophagyAiling Liu0Hongying Wang1Hong Lv2Hong Yang3Yue Li4Jiaming Qian5Department of Gastroenterology, the Affiliated Hospital of Qingdao University, No. 16 Jiangsu Road, Qingdao, Shandong Province, China; Department of Gastroenterology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, ChinaState Key Laboratory of Molecular Oncology, Peking Union Medical College, Beijing, ChinaDepartment of Gastroenterology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, ChinaDepartment of Gastroenterology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, ChinaDepartment of Gastroenterology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, ChinaDepartment of Gastroenterology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China; Corresponding author at: Department of Gastroenterology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 1 Shuaifuyuan Road, Dongcheng District, Beijing 100730, China.Background: The elderly ulcerative colitis (UC) patients pose unique challenges due to their comorbidities, diminished functional capacity, and heightened risk of treatment-related complications. Thus, finding a safe and effective treatment for this age group is crucial. Aim: This study investigates the role of autophagy in the pathogenesis of UC in young and elderly patients, and explores the therapeutic potential and mechanisms of autophagy modulators in aged mice with dextran sulfate sodium (DSS)-induced colitis. Methods: Colonic biopsies were collected from young and old UC patients as well as comparable healthy subjects. Young (6–8 weeks) and aged (56 weeks) C57BL/6 mice were treated with DSS to induce acute colitis model. The autophagy inhibitor 3-methyladenine was administered intraperitoneally to aged DSS-induced mice. The autophagy activity was detected by the protein expressions of LC3B-II, p62 and ATG5 by western blot and immunohistochemistry. The levels of TNF -α, IL-6, CCL4, CXCL12 and CD86 were measured by qRT-PCR. The transcriptional activity of NF-κB was measured by electrophoretic mobility shift assay (EMSA). Results: Increased autophagy activity was observed in aged DSS-induced mice. Treatment with 3-methyladenine suppressed autophagy in intestinal epithelial cells (IECs) and alleviated colitis severity. Additionally, 3-methyladenine reduced macrophage recruitment, decreased IL-6 levels, and inhibited NF-κB signaling, thereby mitigating inflammation. Conclusion: Significant differences in autophagy activity were identified between young and aged DSS-induced mice. These findings underscore the potential therapeutic benefits of autophagy inhibition in elderly UC patients.http://www.sciencedirect.com/science/article/pii/S0531556525000257Cell autophagySenescenceInflammatory bowel diseaseMacrophagyInflammation
spellingShingle Ailing Liu
Hongying Wang
Hong Lv
Hong Yang
Yue Li
Jiaming Qian
Autophagy inhibitor 3-methyladenine mitigates the severity of colitis in aged mice by inhibiting autophagy
Experimental Gerontology
Cell autophagy
Senescence
Inflammatory bowel disease
Macrophagy
Inflammation
title Autophagy inhibitor 3-methyladenine mitigates the severity of colitis in aged mice by inhibiting autophagy
title_full Autophagy inhibitor 3-methyladenine mitigates the severity of colitis in aged mice by inhibiting autophagy
title_fullStr Autophagy inhibitor 3-methyladenine mitigates the severity of colitis in aged mice by inhibiting autophagy
title_full_unstemmed Autophagy inhibitor 3-methyladenine mitigates the severity of colitis in aged mice by inhibiting autophagy
title_short Autophagy inhibitor 3-methyladenine mitigates the severity of colitis in aged mice by inhibiting autophagy
title_sort autophagy inhibitor 3 methyladenine mitigates the severity of colitis in aged mice by inhibiting autophagy
topic Cell autophagy
Senescence
Inflammatory bowel disease
Macrophagy
Inflammation
url http://www.sciencedirect.com/science/article/pii/S0531556525000257
work_keys_str_mv AT ailingliu autophagyinhibitor3methyladeninemitigatestheseverityofcolitisinagedmicebyinhibitingautophagy
AT hongyingwang autophagyinhibitor3methyladeninemitigatestheseverityofcolitisinagedmicebyinhibitingautophagy
AT honglv autophagyinhibitor3methyladeninemitigatestheseverityofcolitisinagedmicebyinhibitingautophagy
AT hongyang autophagyinhibitor3methyladeninemitigatestheseverityofcolitisinagedmicebyinhibitingautophagy
AT yueli autophagyinhibitor3methyladeninemitigatestheseverityofcolitisinagedmicebyinhibitingautophagy
AT jiamingqian autophagyinhibitor3methyladeninemitigatestheseverityofcolitisinagedmicebyinhibitingautophagy